Sonia Maria Soares Ferreira

Sonia Maria Soares Ferreira

Auto-generated profile, based on publicly available information

Sonia Maria Soares Ferreira

Centro Universitário CESMAC

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Ciencia & Saude Coletiva
Verified
Journal Article
Open access
PDF file
KSKarine da Silva Santos
Karine da Silva Santos
MRMara Cristina Ribeiro
Mara Cristina Ribeiro
DQDanlyne Eduarda Ulisses de Queiroga
Danlyne Eduarda Ulisses de Queiroga
ISIvisson Alexandre Pereira da Silva
Ivisson Alexandre Pereira da Silva
SFSonia Maria Soares Ferreira
Sonia Maria Soares Ferreira
Resumo Este artigo objetiva apresentar o uso da triangulação na pesquisa qualitativa como estratégia para atingir os objetivos propostos, garantir credibilidade, confiabilidade e maior rigor científico em sua realização. Nesse sentido, a triangulação – por não se restringir à utilização de apenas um método, teoria, fonte de dados ou investigador no processo de análise de um mesmo fenômeno – possibilita a apreensão de uma dada realidade sob diversos ângulos, possibilitando o confrontamento de informações, de maneira a minimizar vieses resultantes de uma única perspectiva de análise. Com o intuito de evidenciar as possibilidades do uso de tal desenho metodológico, utilizou-se como exemplo um estudo qualitativo sobre vivências de cuidadores de pacientes com neoplasia de cabeça e pescoço, desenvolvido por meio de triangulação múltipla, a saber: triangulação metodológica (intramétodo), de dados, de investigador e ambiental. Ao se demonstrar um estudo estruturado, em forma de triangulação, tem-se como finalidade orientar pesquisadores interessados em realizar estudos qualitativos com um maior aprofundamento e rigor metodológico em pesquisa qualitativa.

1 January 2017 in International Journal of Dentistry
Verified
Journal Article
Open access
PDF file
ACAnna Carolina Omena Vasconcellos Le Campion
Anna Carolina Omena Vasconcellos Le Campion
CRCamila Maria Beder Ribeiro
Camila Maria Beder Ribeiro
RLRonir Luiz
Ronir Luiz
FJFrancisco Feliciano da Silva Júnior
Francisco Feliciano da Silva Júnior
HBHerbert Charles Silva Barros
Herbert Charles Silva Barros
SFSonia Maria Soares Ferreira
Sonia Maria Soares Ferreira
Aim. To assess the epidemiological and clinical factors that influence the prognosis of oral and oropharyngeal squamous cell carcinoma (SCC). Methods. One hundred and twenty-one cases of oral and oropharyngeal SCC were selected. The survival curves for each variable were estimated using the Kaplan-Meier method. The Cox regression model was applied to assess the effect of the variables on survival. Results. Cancers at an advanced stage were observed in 103 patients (85.1%). Cancers on the tongue were more frequent (23.1%). The survival analysis was 59.9% in one year, 40.7% in two years, and 27.8% in 5 years. There was a significant low survival rate linked to alcohol intake (p=0.038), advanced cancer staging (p=0.003), and procedures without surgery (p<0.001). When these variables were included in the Cox regression model only surgery procedures (p=0.005) demonstrated a significant effect on survival. Conclusion. The findings suggest that patients who underwent surgery had a greater survival rate compared with those that did not. The low survival rates and the high percentage of patients diagnosed at advanced stages demonstrate that oral and oropharyngeal cancer patients should receive more attention.

1 November 2020 in Brazilian Journal of Otorhinolaryngology
Verified
Journal Article
Open access
KCKlinger V.T. da Costa
Klinger V.T. da Costa
ACAline Tenório Lins Carnaúba
Aline Tenório Lins Carnaúba
KRKatianne Wanderley Rocha
Katianne Wanderley Rocha
KAKelly Cristina Lira de Andrade
Kelly Cristina Lira de Andrade
SFSonia M.S. Ferreira
Sonia M.S. Ferreira
PMPedro de L. Menezes
Pedro de L. Menezes
The SARS-CoV-2 virus causes COVID-19, and it is responsible for the largest pandemic since the 1918 H1N1 influenza outbreak. The classic symptoms of the disease have been well defined by the World Health Organization; however, olfactory/gustatory disorders have been reported in some studies, but there are still several missing points in the understanding and in the consensus about the clinical management of these cases. To identify evidence in the scientific literature about olfactory/gustatory disorders, their clinical presentation, prevalence and possible specific treatments associated with COVID-19. A systematic review of articles published up to April 25, 2020 was performed in Medline, Cochrane Clinical Trials, ScienceDirect, Lilacs, Scopus and Google Schoolar, OpenGrey.eu, DissOnline, The New York Academy of Medicine and Reasearch Gate. (1) Studies on patients with COVID-19; (2) Records of COVID-19 signs/symptoms, and olfactory/gustatory functions. (1) Studies on non-human coronavirus; (2) Review articles; (3) Experimental studies (in animals or in vitro); (4) Olfactory/gustatory disorders initiated prior to SARS-CoV-2 infection. The risk assessment of bias of the selected studies was performed using the Newcastle-Ottawa scale. Six articles from the 1788 records met the inclusion criteria and were analyzed. A total of 1457 patients of different ethnicities were assessed; of them, 885 (60.7%) and 822 (56.4%) had smell and taste disorders, respectively, with women being most often affected. There were olfactory/gustatory disorders even without nasal obstruction/rhinorrhea and beginning even before the signs/symptoms of COVID-19; the recovery of smell/taste, when it occurs, usually happened in the first two weeks after COVID-19 resolution. There is evidence that olfactory/gustatory disorders are strong predictors of infection by SARS-CoV-2, and it is possible to recommend patient isolation, as early as of the medical consultation, preventing the spread of the virus. No scientific evidence has been identified for effective treatments for any of the disorders. Olfactory/gustatory disorders may occur at varying intensities and prior to the general symptoms of COVID-19 and should be considered as part of the clinical features of COVID-19, even in mild cases. There is still no scientific evidence of specific treatments for such disorders in COVID-19 disease.

24 March 2003 in Dental Traumatology
Verified
Journal Article
Closed access
PDF file
LPLuciana Fernandes Pacheco
Luciana Fernandes Pacheco
PFPaulo Ferreira Garcia Filho
Paulo Ferreira Garcia Filho
ALAriadne Letra
Ariadne Letra
RMRenato Menezes
Renato Menezes
GVGerman Eduardo Miguel Villoria
German Eduardo Miguel Villoria
SFSonia Maria Ferreira
Sonia Maria Ferreira

1 December 2001 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
PDF file
MJMary Ann Jabra-Rizk
Mary Ann Jabra-Rizk
SFS. M. S. Ferreira
S. M. S. Ferreira
MSM. Sabet
M. Sabet
WFW. A. Falkler
W. A. Falkler
WMW. G. Merz
W. G. Merz
TMT. F. Meiller
T. F. Meiller
Oral and subgingival samples from periodontal lesions were collected from 54 human immunodeficiency virus (HIV)-positive and 20 HIV-negative patients and cultured for yeast species. Of the 54 samples cultured from HIV-positive patients, 44 (82%) were positive for yeast species, of which 29 (66%) were subgingival. A total of 19 (48%) patients were positive for Candida dubliniensis , of which 15 (79%) were colonized in subgingival sites. Seven isolates of Candida glabrata , two isolates of Candida parapsilosis , and one isolate of Saccharomyces cerevisiae were recovered. This study reports for the first time the recovery of C. dubliniensis from subgingival intraoral sites and confirms the presence of Candida species in sites of periodontal disease associated with HIV.

1 January 2007 in Journal of Periodontology
Verified
Journal Article
Closed access
Lucio GonçalvesLucio Gonçalves
Lucio Gonçalves
SFSônia Maria Soares Ferreira
Sônia Maria Soares Ferreira
CSCelso Oliveira Souza
Celso Oliveira Souza
RSRenata Souto
Renata Souto
ACAna Paula Colombo
Ana Paula Colombo
Background: This study compares the periodontal clinical profile and the composition of the subgingival microbiota of human immunodeficiency virus (HIV)‐seropositive and HIV‐seronegative subjects with chronic periodontitis.Methods: A total of 172 subjects were distributed into two HIV‐seropositive groups (37 chronic periodontitis [H+CP+] and 35 periodontally healthy [H+CP−] individuals) and two HIV‐seronegative groups (49 chronic periodontitis [H−CP+] and 51 periodontally healthy [H−CP−] subjects). Subgingival samples were collected from six sites with the deepest probing depth in the periodontitis groups and six random sites in the groups with periodontal health. All HIV‐infected patients had undergone highly active antiretroviral therapy (HAART) for at least 2 years. The presence and levels of 33 bacterial species were detected by DNA probes and the checkerboard method. Kruskal‐Wallis and Mann‐Whitney tests were used to seek for significant differences among and between groups.Results: H−CP+ patients showed significantly more periodontal destruction and inflammation than H+CP+ patients, whereas H+CP− subjects presented a greater percentage of sites with bleeding than H−CP− subjects (P <0.01). Patients who were HIV seronegative showed higher prevalence and levels of most bacterial species than HIV seropositive patients. Periodontal pathogens including Tannerella forsythensis, Porphyromonas gingivalis, Prevotella nigrescens, Eubacterium nodatum, Fusobacterium nucleatum, and Selenomonas noxia were more frequently detected in H−CP+ subjects compared to H+CP+ and controls. In contrast, Enterococcus faecalis and Acinetobacter baumannii were more commonly found in HIV‐infected than in non–HIV‐infected subjects (P <0.05).Conclusion: Putative periodontal pathogens are more prevalent in the subgingival microbiota of HIV‐seronegative patients with chronic periodontitis, whereas species not usually associated with periodontitis are detected in higher frequency in HIV‐seropositive subjects under HAART.